Alleviation of Mechanical Allodynia by 14,15-Epoxyeicosatrienoic Acid in a Central Poststroke Pain Model: Possible Role of Allopregnanolone and Delta-Subunit-Containing Gamma-Aminobutyric Acid A Receptors
November 2018
in “
The journal of pain/Journal of pain
”
TLDR 14,15-EET may help reduce poststroke pain by affecting certain brain proteins.
The study investigated the effects of 14,15-epoxyeicosatrienoic acid (14,15-EET) on mechanical allodynia in a central poststroke pain (CPSP) model using rats. It found that 14,15-EET alleviated mechanical allodynia by enhancing StAR-AP-δGABAAR signaling, showing greater efficacy than gabapentin. The antinociceptive effect was negated by inhibitors of 5α-reductase or GABAAR antagonists, suggesting that 14,15-EET could be a potential therapeutic agent for CPSP by restoring normal thalamic inhibition through AP-δGABAAR signaling. The study involved groups of 5 to 10 rats per experiment.